These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 30576232)

  • 41. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-198 regulated the tumorigenesis of gastric cancer by targeting Toll-like receptor 4 (TLR4).
    Quan XQ; Xie ZL; Ding Y; Feng R; Zhu XY; Zhang QX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2287-2296. PubMed ID: 29762851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulated miR-132 in Lgr5
    Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
    Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis.
    Cheng W; Luan P; Jin X
    Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
    Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
    Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
    Xu Y; Zhao S; Cui M; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.
    Xu B; Guo J; Chen M
    Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1105-1115. PubMed ID: 35748299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
    Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
    Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway.
    Dong XZ; Song Y; Lu YP; Hu Y; Liu P; Zhang L
    J Nat Med; 2019 Sep; 73(4):777-788. PubMed ID: 31243669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
    Wang C; Wang C; Qiu C; Su Z
    Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
    [No Abstract]   [Full Text] [Related]  

  • 55. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
    Wen L; Cheng F; Zhou Y; Yin C
    Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.
    Chen Z; Li Z; Soutto M; Wang W; Piazuelo MB; Zhu S; Guo Y; Maturana MJ; Corvalan AH; Chen X; Xu Z; El-Rifai WM
    Gastroenterology; 2019 Mar; 156(4):1127-1139.e8. PubMed ID: 30502323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.